Privi Speciality Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on December 19, 2025 to consider & Approve Scheme of Amalgamation
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Privi Speciality Chemicals met on December 19, 2025 and approved a Scheme of Amalgamation. The filing does not name the merging entity or disclose the share swap ratio in this announcement. A scheme of amalgamation is typically the first formal step before shareholder voting and NCLT approvals. Investors should look out for the next filings which are likely to detail the counterparty, swap/exchange ratio and the rationale for the merger. Until those details are out, the precise financial impact on shareholders remains unclear.
Neutral to mildly positive in the short term as approval signals progress on a corporate restructuring. Final impact on share price and shareholder value will depend on the swap ratio, the identity of the merging entity, and whether NCLT and shareholders approve the deal.